Bachelors Degree in Pharmacy from a recognized institute. OR Diploma in pharmacy The candidate should be registered in state pharmacy council. State AIDS Control Society
Masters or Ph.D. in Biochemistry/ Biotechnology/ Microbiology/ Botany/ Pharmaceutical Sciences/ Molecular Biology/ Bioinformatic/ Biological Sciences. National Botanical Research Institute
MSc in Life Sciences / Biomedical Sciences / Biochemistry / Physiology / Biotechnology / Molecular Biology / Microbiology / Cancer Biology. King Georges Medical University, KGMU
Post Graduate degree in Life sciences subjects / Biochemistry / Biotechnology / Immunology / Molecular Biology with first division at both graduation and post graduate level and the applicant should be 28 years as on 1st April of the year.
Candidates having hands-on experience in solution and solid phase peptide synthesis, purification using RP-HPLC, synthesis of non-natural amino acids and peptides will be preferred.
Masters Degree in Life Sciences / Biotechnology. Genome-wide association mapping of important agronomic traits in the climate- resilient crop little millet at Institute of Life Sciences Add to Default shortcuts
M.Sc., or equivalent degree in Life Sciences with minimum 55% of marks with research experience in molecular biology, cell culture and passing of NET, GATE test.
B.Pharma/ BSc along with MBA. Senior Marketing Specialist - Neuromodulation. Directs the development of company market requirements for specific products or product line
M.Pharm / B.Pharm, M.Sc Openings For Green Field Injectable Facility of Biovonic Healthcare. Production Injectable, Quality Assurance GMP Documentation, Quality Control, Microbiology
Scientist Pharmaceutical Development at Aurigene. Plan and execute pre-formulation studies, stability studies etc for mAB and ADC projects during early stages of pre-clinical development.
BTech / Masters in Technology or Masters in Business Administration. The Execution QA comprehensively reviews rendering quality, Metadata, Content Matrices. Novartis
Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, chemotherapy, and immunotherapy. But a new discovery may change the way doctors approach treatment.
The theme of the conference, explores how the pharmaceutical industry can drive positive change by implementing sustainable practices, advancing green chemistry, reducing environmental impact and enhancing access to life-saving medicines